Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Haleh Davanian, Anangi Balasiddaiah, Robert Heymann, Magnus Sundström, Poppy Redenström, Mikael Silfverberg, David Brodin, Matti Sällberg, Sven Lindskog, Carina Kruger Weiner, Margaret Chen
Published Dec 10, 2016 · Vol. 8, No. 3 · pp. 4530-4542
Silvio Däster, Nunzia Amatruda, Diego Calabrese, Robert Ivanek, Eleonora Turrini, Raoul A. Droeser, Paul Zajac, Carmela Fimognari, Giulio C. Spagnoli, Giandomenica Iezzi, Valentina Mele, Manuele G. Muraro
Published Dec 10, 2016 · Vol. 8, No. 1 · pp. 1725-1736
Sirichat Kaowinn, Jeonghyo Kim, Jaebeom Lee, Dong Hoon Shin, Chi-Dug Kang, Dae-Kee Kim, Soojin Lee, Min Kyung Kang, Sang Seok Koh, Seong-Jin Kim, Young-Hwa Chung
Published Dec 10, 2016 · Vol. 8, No. 3 · pp. 5092-5110